The rates of obesity across the globe and particularly in the Western world are increasing and the number of gastric bypass surgeries needed are going up with it. As a result, Boston-based company Allurion has created a gastric balloon that works as gastric bypass surgery would, but in a completely non-invasive way.
Called the Elipse, the gastric balloon comes in the form of a pill and inflates the stomach within 15 minutes of being swallowed. The balloon remains in the stomach for four months, after which it opens on its own and is excreted through the digestive system.
The company believes that their product is of much lower risk than other, more invasive forms of gastric bypass. The Elipse is currently available in parts of Europe and the company hopes to receive FDA approval so that it can sell its product within the United States, where obesity rates are at an all-time high.
What Makes This Trend Stand Out
- Non-invasive Gastric Balloons
- Opportunities for creating more non-invasive solutions in the field of weight loss and bariatric surgery.
- Medical Devices in Pill Form
- Opportunities for creating more medical devices that can be taken in a non-invasive way through pill form.
- Obesity Management
- Opportunities for developing new and innovative strategies to manage and treat obesity.
Sectors Adopting This
- Medical Devices
- Opportunities for medical device companies to create non-invasive solutions that can help manage obesity and other medical conditions.
- Pharmaceuticals
- Opportunities for pharmaceutical companies to develop more effective weight loss drugs and non-invasive delivery methods.
- Healthcare
- Opportunities for healthcare professionals to provide more comprehensive and effective strategies for managing and treating obesity.
